ASEP Medical Holdings Inc.
ASEP
CNSX
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | -8.53% | 22.08% | 49.59% | 46.55% | -9.42% |
| Depreciation & Amortization | 0.64% | 0.78% | -0.48% | -2.75% | 5.67% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -18.25% | 4.51% | 22.75% | 27.64% | 1.66% |
| Operating Income | 22.56% | -1.18% | -20.70% | -27.20% | -1.66% |
| Income Before Tax | 34.36% | 21.65% | -15.47% | -47.73% | -24.47% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 33.65% | 20.75% | -17.03% | -49.92% | -23.15% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -31.66% | -28.65% | -22.87% | -5.56% | 13.25% |
| Net Income | 34.01% | 19.09% | -27.90% | -64.96% | -25.14% |
| EBIT | 22.56% | -1.18% | -20.70% | -27.20% | -1.66% |
| EBITDA | 29.39% | -1.20% | -28.63% | -38.20% | -0.85% |
| EPS Basic | 45.03% | 31.29% | -14.09% | -49.84% | -11.60% |
| Normalized Basic EPS | 33.89% | 11.60% | -24.10% | -33.11% | 16.59% |
| EPS Diluted | 45.03% | 31.29% | -14.09% | -49.84% | -11.60% |
| Normalized Diluted EPS | 33.89% | 11.60% | -24.10% | -33.11% | 16.59% |
| Average Basic Shares Outstanding | 23.21% | 21.67% | 16.38% | 10.72% | 9.81% |
| Average Diluted Shares Outstanding | 23.21% | 21.67% | 16.38% | 10.72% | 9.81% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
